Evidence map›Paper›PMID 35574159›Full record

ArticleCurrent opinion in biomedical engineering2022

Tissue Engineering for Cervical Function in Pregnancy.

Yali Zhang, David Kaplan, Michael D House

Abstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yali ZhangMother Infant Research Institute, Tufts Medical Center, Boston, MA, USA.
David KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.
Michael D HouseMother Infant Research Institute, Tufts Medical Center, Boston, MA, USA.

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
Injectable Gels for Tissue AugmentationR01EB021264 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI HOUSE, MICHAEL DOUGLAS, KAPLAN, DAVID L. · 2016 to 2019
$1.4M
NIBIB NIH HHS P41 EB027062NIBIB NIH HHS R01 EB021264NICHD NIH HHS K12 HD000849
6 · The paper itself

Abstract

Cervical insufficiency is a significant obstetrical complication that causes preterm birth. The current treatment of cervical insufficiency is cerclage surgery. A cerclage is a suture that is placed around the cervix to provide compression support. The load bearing portion of the cervix is the stroma, which is composed of collagen-rich extracellular matrix. A remarkable feature of the cervix is progressive softening throughout gestation. The biochemical mechanisms of cervical softening, however, are poorly understood. In this narrative review, we discuss our approach to using tissue engineering techniques to study cervical function in pregnancy. A brief review of the clinical significance of the cervix in pregnancy is presented. The development of a tissue engineering model for studying cervical remodeling is discussed. We also discuss an engineered injectable hydrogel as an alternate treatment for cervical dysfunction. We advocate for a bioengineering approach to study cervical dysfunction in pregnancy.

Identifiers

PMID35574159
PMCPMC9097905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.